A South Korean biotech working on multi-specific autoimmune disease treatments is looking to make a leap into the US. Curogen, based in Seoul and backed by local investors, announced Monday that it plans to open …
A South Korean biotech working on multi-specific autoimmune disease treatments is looking to make a leap into the US. Curogen, based in Seoul and backed by local investors, announced Monday that it plans to open …
@ 2025 Pharminent. All rights reserved